ICD-11 code 1A91 represents the diagnosis of Granuloma inguinale, a rare sexually transmitted bacterial infection caused by the bacterium Klebsiella granulomatis. This condition is typically characterized by painless ulcers or nodules in the genital area, which can be mistaken for other types of sexually transmitted infections.
Granuloma inguinale primarily affects the skin and mucous membranes of the genital region, but can also spread to other parts of the body if left untreated. The ulcers or nodules associated with this condition may be slow to heal and can lead to complications such as scarring or tissue damage.
Treatment for Granuloma inguinale typically involves a course of antibiotics, such as doxycycline or azithromycin, to eliminate the bacteria causing the infection. It is important for individuals with symptoms of Granuloma inguinale to seek medical attention promptly to prevent the spread of the infection and reduce the risk of complications.
Table of Contents:
- #️⃣ Coding Considerations
- 🔎 Symptoms
- 🩺 Diagnosis
- 💊 Treatment & Recovery
- 🌎 Prevalence & Risk
- 😷 Prevention
- 🦠 Similar Diseases
#️⃣ Coding Considerations
In the world of medical coding, the SNOMED CT code equivalent to the ICD-11 code 1A91 for Granuloma inguinale is 31394009. This SNOMED CT code specifically refers to the presence of donovanosis, the bacterial infection responsible for causing granuloma inguinale. By using this code, healthcare professionals can accurately document and communicate information about this rare ulcerative genital disease. The code enables standardized data sharing and comparability, streamlining the process of disease diagnosis and treatment. With the adoption of SNOMED CT as the global standard for clinical terminology, the ability to accurately code and classify granuloma inguinale cases has been greatly improved, leading to more efficient healthcare practices and improved patient care outcomes.
In the United States, ICD-11 is not yet in use. The U.S. is currently using ICD-10-CM (Clinical Modification), which has been adapted from the WHO’s ICD-10 to better suit the American healthcare system’s requirements for billing and clinical purposes. The Centers for Medicare and Medicaid Services (CMS) have not yet set a specific date for the transition to ICD-11.
The situation in Europe varies by country. Some European nations are considering the adoption of ICD-11 or are in various stages of planning and pilot studies. However, as with the U.S., full implementation may take several years due to similar requirements for system updates and training.
🔎 Symptoms
Symptoms of Granuloma inguinale (1A91) typically include painless ulceration in the genital area, particularly in the groin and perianal regions. These ulcers often begin as small, red papules that gradually enlarge and erode, forming a thick, beefy-red, granular base. The ulcers may bleed easily and have a characteristic appearance of “beefy red” or “raspberry-like” lesions.
In advanced cases of Granuloma inguinale, the ulcers may become chronic and spread to involve the surrounding skin, leading to extensive tissue destruction. In some instances, secondary bacterial infections may occur in the ulcerated areas, causing additional symptoms such as foul-smelling discharge, pain, and fever. The infection can also spread to nearby lymph nodes, resulting in swelling and tenderness in the groin area.
Granuloma inguinale may also present with asymptomatic, raised, beefy-red granulomatous lesions called “pseudo-buboes” in the genital region. These nodules are non-tender and can vary in size from small papules to larger nodular masses. In rare cases, patients may experience systemic symptoms such as malaise, weight loss, and anemia, indicating a more severe and widespread infection that requires urgent medical attention.
🩺 Diagnosis
Diagnosis of Granuloma inguinale (1A91) typically involves a physical examination of the affected area. Healthcare providers will look for characteristic symptoms such as painless ulcers or sores in the genital region. In some cases, a tissue sample may be taken from the ulcer to confirm the presence of the causative bacteria, Klebsiella granulomatis.
Laboratory tests such as polymerase chain reaction (PCR) may be used to detect the DNA of Klebsiella granulomatis in a tissue sample. Blood tests can also help to rule out other possible causes of the symptoms. Additionally, healthcare providers may perform a pelvic exam to check for any signs of infection or inflammation in the genital region.
A diagnosis of Granuloma inguinale may also involve a thorough medical history review, including sexual history and any recent travel to regions where the disease is more common. It is important for healthcare providers to consider all relevant information to accurately diagnose and treat the condition. Proper diagnosis is essential to initiate appropriate treatment and prevent complications associated with Granuloma inguinale.
💊 Treatment & Recovery
Treatment for Granuloma inguinale typically involves antibiotic therapy. The preferred antibiotics for treating this condition are usually either doxycycline or azithromycin. Treatment with antibiotics is usually continued until all lesions have healed, which can take several weeks.
In cases where there is severe tissue damage or if the infection does not respond to antibiotics, surgical intervention may be necessary. This could involve removing the infected tissue or draining abscesses. It is important for individuals with Granuloma inguinale to be closely monitored by a healthcare provider to ensure appropriate treatment and recovery.
Recovery from Granuloma inguinale can vary depending on the severity of the infection and how quickly it is diagnosed and treated. With prompt and appropriate treatment, most individuals can recover fully from this infection. It is important for individuals to follow their healthcare provider’s recommendations for antibiotics and to attend follow-up appointments to ensure proper healing.
🌎 Prevalence & Risk
In the United States, Granuloma inguinale is considered a rare disease with only a few reported cases each year. The exact prevalence is difficult to determine due to underreporting and misdiagnosis. However, cases have been reported in various states across the country.
In Europe, Granuloma inguinale is also considered rare, with sporadic cases reported in countries such as the United Kingdom, Germany, and Italy. The prevalence of the disease in Europe is thought to be low compared to other regions, but accurate data is limited.
In Asia, Granuloma inguinale is more commonly reported in countries such as India, Papua New Guinea, and Indonesia. The disease is considered endemic in certain regions, particularly in tropical and subtropical areas where the bacterium responsible for the infection thrives.
In Africa, Granuloma inguinale has been reported in countries such as South Africa, Nigeria, and Kenya. The prevalence of the disease in Africa is thought to be higher compared to other regions, with cases primarily concentrated in regions with poor access to healthcare and sanitation.
😷 Prevention
To prevent 1A91 (Granuloma inguinale), individuals should practice safe sexual practices, including using condoms during intercourse to reduce the risk of transmission. Avoiding sexual contact with individuals who have symptoms of the disease, such as genital ulcers, can also help prevent the spread of the infection. It is important for individuals who have been diagnosed with Granuloma inguinale to seek treatment and complete the full course of antibiotics to prevent further spread and recurrence of the disease.
Regular screening for sexually transmitted infections, including 1A91 (Granuloma inguinale), can help identify infections early and prevent further transmission. It is recommended that individuals who are sexually active with multiple partners or who engage in risky sexual behaviors undergo regular testing for sexually transmitted infections to prevent the spread of diseases such as Granuloma inguinale. Education and awareness about sexually transmitted infections, including signs and symptoms of Granuloma inguinale, can also help individuals take necessary precautions to prevent infection and transmission of the disease.
🦠 Similar Diseases
One disease similar to Granuloma inguinale (1A91) is lymphogranuloma venereum (A55). Lymphogranuloma venereum is caused by infection with certain serovars of Chlamydia trachomatis and primarily affects the lymphatic system in the genital region. Like Granuloma inguinale, lymphogranuloma venereum is characterized by painful ulcers and inguinal lymphadenopathy. However, lymphogranuloma venereum tends to have a more systemic presentation with systemic symptoms such as fever and malaise.
Another disease closely related to Granuloma inguinale is chancroid (A57). Chancroid is a sexually transmitted infection caused by the bacterium Haemophilus ducreyi. Like Granuloma inguinale, chancroid presents with painful genital ulcers, but the ulcers in chancroid are more likely to be soft, friable, and bleed easily. Additionally, chancroid is more commonly associated with inguinal lymphadenopathy and may present with multiple ulcers in the genital region.
Mycobacterium marinum infection (1A90) can also bear similarities to Granuloma inguinale. Mycobacterium marinum is a slow-growing atypical mycobacterium that can cause skin and soft tissue infections, typically acquired from aquatic environments. Infection with Mycobacterium marinum can present with nodular lesions that may ulcerate and form granulomas. While not typically involving the genital region like Granuloma inguinale, Mycobacterium marinum infection can sometimes resemble granuloma formation seen in Granuloma inguinale.